Bremazocine
Bremazocine
Bremazocine (pronounced: bre-ma-zo-cine) is a kappa opioid receptor agonist. It is a synthetic compound derived from benzomorphan.
Etymology
The term "Bremazocine" is derived from the combination of the words "benzomorphan" and "azocine". "Benzomorphan" is a chemical compound used as a base in the synthesis of various drugs, while "azocine" is a seven-membered heterocyclic chemical compound containing one nitrogen atom.
Pharmacology
Bremazocine is a potent kappa opioid receptor agonist. This means it binds to and activates the kappa opioid receptors in the brain, which are involved in pain perception, consciousness, motor control, and mood. As an agonist, Bremazocine can produce analgesic effects, but it can also cause side effects such as sedation and dysphoria.
Related Terms
- Kappa opioid receptor: A type of opioid receptor that Bremazocine binds to and activates.
- Agonist: A chemical that binds to a receptor and activates the receptor to produce a biological response.
- Benzomorphan: A chemical compound used as a base in the synthesis of various drugs, including Bremazocine.
- Azocine: A seven-membered heterocyclic chemical compound containing one nitrogen atom. Part of the structure of Bremazocine.
See Also
External links
- Medical encyclopedia article on Bremazocine
- Wikipedia's article - Bremazocine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski